PIN6 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIVIRAL COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS C ADMINISTERED ACCORDING TO THE NEW GENOTYPESPECIFIC GUIDELINES
Abstract
Authors
U Siebert G Sroczynski P Aidelsburger S Rossol J Wasem MP Manns JG McHutchison JB Wong